BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16449944)

  • 1. Activation of genes inducing cell-cycle arrest and of increased DNA repair in the hearts of rats with early streptozotocin-induced diabetes mellitus.
    Golubnitschaja O; Moenkemann H; Trog DB; Blom HJ; De Vriese AS
    Med Sci Monit; 2006 Feb; 12(2):BR68-74. PubMed ID: 16449944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
    Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
    J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21WAF1/CIP1 and 14-3-3 sigma gene expression in degenerated aortic valves: a link between cell cycle checkpoints and calcification.
    Golubnitschaja O; Yeghiazaryan K; Skowasch D; Schild H; Bauriedel G
    Amino Acids; 2006 Oct; 31(3):309-16. PubMed ID: 16953367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats.
    Yu BC; Chang CK; Ou HY; Cheng KC; Cheng JT
    Cardiovasc Res; 2008 Oct; 80(1):78-87. PubMed ID: 18573863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
    Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
    Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early molecular events in the development of the diabetic cardiomyopathy.
    Mönkemann H; De Vriese AS; Blom HJ; Kluijtmans LA; Heil SG; Schild HH; Golubnitschaja O
    Amino Acids; 2002; 23(1-3):331-6. PubMed ID: 12373555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling.
    Stilli D; Lagrasta C; Berni R; Bocchi L; Savi M; Delucchi F; Graiani G; Monica M; Maestri R; Baruffi S; Rossi S; Macchi E; Musso E; Quaini F
    Basic Res Cardiol; 2007 Nov; 102(6):488-99. PubMed ID: 17585379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level.
    Feng B; Chen S; Chiu J; George B; Chakrabarti S
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1119-26. PubMed ID: 18413674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression changes of mitogen-activated protein kinase phosphatase-1 (MKP-1) in myocardium of streptozotocin-induced diabetic rats.
    Weng Y; Shen F; Li J; Shen Y; Zhang X
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):455-60. PubMed ID: 17647144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy.
    Dvoráková MC; Pfeil U; Kuncová J; Svíglerová J; Galvis G; Krasteva G; König P; Grau V; Slavíková J; Kummer W
    Cell Tissue Res; 2006 Mar; 323(3):383-93. PubMed ID: 16344947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes.
    He X; Kan H; Cai L; Ma Q
    J Mol Cell Cardiol; 2009 Jan; 46(1):47-58. PubMed ID: 19007787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage and expression of checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in taurine-deficient cardiomyocytes.
    Golubnitschaja O; Moenkemann H; Kim K; Mozaffari MS
    Biochem Pharmacol; 2003 Aug; 66(3):511-7. PubMed ID: 12907251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted G1 to S phase clearance via cyclin signaling impairs liver tissue repair in thioacetamide-treated type 1 diabetic rats.
    Devi SS; Mehendale HM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2):89-102. PubMed ID: 15953624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats.
    Kuo WW; Chung LC; Liu CT; Wu SP; Kuo CH; Tsai FJ; Tsai CH; Lu MC; Huang CY; Lee SD
    Cell Biochem Funct; 2009 Oct; 27(7):479-87. PubMed ID: 19718675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal failure during sepsis: potential role of cell cycle regulation.
    Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
    J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
    J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
    Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
    Yildirim SS; Akman D; Catalucci D; Turan B
    Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Gsalpha compensates for myocyte loss in diabetic cardiomyopathy.
    Malhotra A; Kang BP; Vashistha H; Yadav VS; Meggs LG
    Can J Physiol Pharmacol; 2008 Mar; 86(3):122-30. PubMed ID: 18418439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.